NKGEN Biotech
CA - Santa AnaBiotechnology
Focus: NKGEN Biotech is a publicly traded biotech company focused on autologous and allogeneic natural killer cell therapies for gene therapy and cell therapy applications. The company is early-stage with a pipeline spanning neurodegenerative diseases, oncology, and immunology.
Profile data last refreshed 14h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
1
Should You Work at NKGEN Biotech?
AI assessmentNKGEN is a speculative early-stage play best suited for risk-tolerant scientists seeking deep pipeline involvement; hiring freeze and pre-Phase 3 stage create execution risk.
Why Work Here
- Emerging cell therapy platform with FDA-active programs in high-value indications (Alzheimer's, oncology, psoriasis) offering exposure to cutting-edge immunotherapy science
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
8 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Clinical Trials (1)
NCT05990920Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy
Phase 1Help build intelligence for NKGEN Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.